Vikrant Madhukar Bhor

Dr. Vikrant Madhukar Bhor

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Anaerobe
Verified
Journal Article
Closed access
PSParul Shishpal
Parul Shishpal
NKNandini Kasarpalkar
Nandini Kasarpalkar
DSDipty Singh
Dipty Singh
VBVikrant Madhukar Bhor
Vikrant Madhukar Bhor

3 May 2021 in VirusDisease
Verified
Journal Article
Closed access
PDF file
KMKiran Munne
Kiran Munne
VBVenkanna Bhanothu
Venkanna Bhanothu
VBVikrant Madhukar Bhor
Vikrant Madhukar Bhor
Vainav PatelVainav Patel
Vainav Patel
SMSmita D. Mahale
Smita D. Mahale
SPShailesh Pande
Shailesh Pande


1 March 2021 in Microbial Pathogenesis
Verified
Journal Article
Closed access
Seema KumariSeema Kumari
Seema Kumari
VBVikrant Madhukar Bhor
Vikrant Madhukar Bhor

24 January 2022 in Journal of Leukocyte Biology
Verified
Journal Article
Closed access
PDF file
ASAmit Kumar Singh
Amit Kumar Singh
NKNandini Kasarpalkar
Nandini Kasarpalkar
SBShilpa Bhowmick
Shilpa Bhowmick
GPGaurav Paradkar
Gaurav Paradkar
MTMayur Talreja
Mayur Talreja
Vainav PatelVainav Patel
Vainav Patel

7 April 2025 in Discover Immunity
Verified
Journal Article
Open access
PDF file
RPRohan R. Pawar
Rohan R. Pawar
PBParul Bardeskar
Parul Bardeskar
VBVikrant Madhukar Bhor
Vikrant Madhukar Bhor
Bacterial extracellular vesicles (BEVs) are considered an efficient platform for vaccine development due to their robust immunomodulatory potential and ability to deliver antigens in their native structure. This review explores the potential of BEVs in infection control, highlighting their role in modulating host immune responses and their applications as immunization candidates. It covers BEV biogenesis, functionality, and the environmental cues influencing BEV production. Furthermore, the interaction of BEVs with immune and non-immune cells is discussed, detailing the mechanisms by which they enhance antigen presentation, induce immunological memory, and alter immune tolerance. The immune dynamics, influencing factors, and regulatory processes are thoroughly examined through insights from studies on T and B cell subsets. This comprehensive overview proposes the potential of harnessing BEVs as effective vaccine contenders in combating infectious diseases while identifying the challenges and opportunities that lie ahead in this field.